Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19

Convalescent plasma has emerged as a promising therapeutic agent for patients with coronavirus disease 2019 (COVID-19), has received emergency use authorization, and is being widely used during the COVID-19 pandemic. Passive antibody therapy via plasma or serum has been successfully used to treat in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Microbiol Newsl
Autors principals: Ripoll, Juan G., van Helmond, Noud, Senefeld, Jonathon W., Wiggins, Chad C., Klassen, Stephen A., Baker, Sarah E., Larson, Kathryn F., Murphy, Brenna M., Andersen, Kylie J., Ford, Shane K., Casadevall, Arturo, Joyner, Michael J.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7862032/
https://ncbi.nlm.nih.gov/pubmed/33564204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clinmicnews.2021.02.001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars